CALIFORNIA CODE OF REGULATIONS
Regulations pertaining to the Controlled Substance Utilization Review and Evaluation System (CURES) can be found at California Code of Regulations, title 11, chapter 8.5.
HISTORY OF THE CURES REGULATIONS
July 1, 2020
On July 1, 2020, the Department promulgated regulations regarding the access and use of CURES, as required by AB-1751 (Statutes of 2018, Chapter 478). This package included, among other things, the following information:
- The process for approving, denying, and disapproving individuals or entities seeking access to information in CURES.
- The purposes for which a health care practitioner may access information in CURES.
- The conditions under which a warrant, subpoena, or court order is required for a law enforcement agency to obtain information from CURES as part of a criminal investigation.
- The process by which information in CURES may be provided for educational, peer review, statistical, or research purposes.
- The requirements surrounding interstate data sharing of prescription drug monitoring information.
August 15, 2022
On August 15, 2022, the Department revised the CURES regulations as a result of AB-528 (Statutes of 2019, Chapter 677) and the implementation of system updates to CURES. The following noteworthy revisions or additions to the regulations were made in this subsequent package:
- Addition of the Non-DEA Practitioner user role.
- Expansion of the existing Delegate functionality.
- Revision of the Interstate Data Sharing requirements.
- Implementation of a new pre-approval process for Law Enforcement-Users obtaining a Patient Activity Report.
- Revision of the Bona Fide Researchers access to Identified Individual-Level Data requirements.
- Addition of Schedule V to the Applicable Controlled Substance definition.
Relevant information concerning current and past regulations may be found at https://oag.ca.gov/jdis/regs#cures.